WHAT IS PULMONARY ARTERIAL HYPERTENSION (PAH)? Pulmonary Arterial Hypertension (PAH) is a severe and progressive form of pulmonary hypertension, characterised by elevated blood pressure in the ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

Scientists found altered activity of the PUM1 protein plays a key role in pulmonary hypertension development, making it a PH treatment target.

Active ingredient: Riociguat 0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg; tabs. Indication: Treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4) after surgical ...

Pulmonary thromboendarterectomy is a surgery used to treat chronic thromboembolic pulmonary hypertension. It’s the treatment of choice for this condition. Chronic thromboembolic pulmonary hypertension ...

There are many types of respiratory diseases, such as COPD, asthma, and obstructive sleep apnea. Smoking and exposure to certain substances are common risk factors. Respiratory diseases are conditions ...